India Pharma Market: Nifty Pharma index has seen a decline of 4% in November. While the selling pressure in the domestic markets has led to the this decline, the Indian Pharma Market growth also was not very encouraging in October albeit on a high base. In October’24, Indian Pharma Market continued to exhibit moderate growth of sub 5% Year on …
Investors cheered the better-than-expected quarterly earnings reports from Reliance and ICICI Bank which lifted the mood of the market. Private sector lender Tamilnad Mercantile Bank on Monday posted a 11.45 per cent rise in its net profit for the fourth quarter ended March 2023 at ₹253 crore, helped by decline in bad loans. Media index drags as it sheds more …
The fresh wave of Covid-19 in the country has pushed up sales of medicines and resulted in exponential growth for the pharmaceutical sector. According to total sales audit data from world’s largest pharmaceutical market research firm IMS Health, the Indian Pharma Market grew 59 per cent yoy in April, 2021 vs 16 per cent yoy in March, 2021 due to …
The Indian pharmaceutical market grew 8.5 per cent year-on-year during December 2020, due to volume and price growth as well as new launches, India Ratings and Research said in a report. Accordingly, the report cited a YoY volume growth of 0.3 per cent, price growth of 5 per cent and products launches at 3.1 per cent during December 2020. “During …
)
)